358 related articles for article (PubMed ID: 17276175)
1. Adiponectin and cardiovascular disease: response to therapeutic interventions.
Han SH; Quon MJ; Kim JA; Koh KK
J Am Coll Cardiol; 2007 Feb; 49(5):531-8. PubMed ID: 17276175
[TBL] [Abstract][Full Text] [Related]
2. Antiatherosclerotic and anti-insulin resistance effects of adiponectin: basic and clinical studies.
Han SH; Sakuma I; Shin EK; Koh KK
Prog Cardiovasc Dis; 2009; 52(2):126-40. PubMed ID: 19732605
[TBL] [Abstract][Full Text] [Related]
3. The role of adiponectin in obesity, diabetes, and cardiovascular disease.
Kawano J; Arora R
J Cardiometab Syndr; 2009; 4(1):44-9. PubMed ID: 19245516
[TBL] [Abstract][Full Text] [Related]
4. Adiponectin and the metabolic syndrome: mechanisms mediating risk for metabolic and cardiovascular disease.
Lara-Castro C; Fu Y; Chung BH; Garvey WT
Curr Opin Lipidol; 2007 Jun; 18(3):263-70. PubMed ID: 17495599
[TBL] [Abstract][Full Text] [Related]
5. Adiponectin: linking the metabolic syndrome to its cardiovascular consequences.
Rabin KR; Kamari Y; Avni I; Grossman E; Sharabi Y
Expert Rev Cardiovasc Ther; 2005 May; 3(3):465-71. PubMed ID: 15889974
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory markers and the metabolic syndrome: insights from therapeutic interventions.
Koh KK; Han SH; Quon MJ
J Am Coll Cardiol; 2005 Dec; 46(11):1978-85. PubMed ID: 16325028
[TBL] [Abstract][Full Text] [Related]
7. Lifestyle modification and endothelial function in obese subjects.
Hamdy O
Expert Rev Cardiovasc Ther; 2005 Mar; 3(2):231-41. PubMed ID: 15853597
[TBL] [Abstract][Full Text] [Related]
8. Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases.
Cersosimo E; DeFronzo RA
Diabetes Metab Res Rev; 2006; 22(6):423-36. PubMed ID: 16506274
[TBL] [Abstract][Full Text] [Related]
9. Reciprocal relationships between abnormal metabolic parameters and endothelial dysfunction.
Han SH; Quon MJ; Koh KK
Curr Opin Lipidol; 2007 Feb; 18(1):58-65. PubMed ID: 17218834
[TBL] [Abstract][Full Text] [Related]
10. Adiponectin, obesity, and cardiovascular disease.
Fasshauer M; Paschke R; Stumvoll M
Biochimie; 2004 Nov; 86(11):779-84. PubMed ID: 15589686
[TBL] [Abstract][Full Text] [Related]
11. Physiological and pathophysiological roles of adiponectin and adiponectin receptors in the integrated regulation of metabolic and cardiovascular diseases.
Yamauchi T; Kadowaki T
Int J Obes (Lond); 2008 Dec; 32 Suppl 7():S13-8. PubMed ID: 19136982
[TBL] [Abstract][Full Text] [Related]
12. Adipokines in diabetes and cardiovascular diseases.
Kralisch S; Sommer G; Deckert CM; Linke A; Bluher M; Stumvoll M; Fasshauer M
Minerva Endocrinol; 2007 Sep; 32(3):161-71. PubMed ID: 17912155
[TBL] [Abstract][Full Text] [Related]
13. Genetic influences of adiponectin on insulin resistance, type 2 diabetes, and cardiovascular disease.
Menzaghi C; Trischitta V; Doria A
Diabetes; 2007 May; 56(5):1198-209. PubMed ID: 17303804
[TBL] [Abstract][Full Text] [Related]
14. Adiponectin in health and disease.
Oh DK; Ciaraldi T; Henry RR
Diabetes Obes Metab; 2007 May; 9(3):282-9. PubMed ID: 17391153
[TBL] [Abstract][Full Text] [Related]
15. [Leptin to adiponectin ratio, as an index of insulin resistance and atherosclerosis development].
Kieć-Klimczak M; Malczewska-Malec M; Huszno B
Przegl Lek; 2008; 65(12):844-9. PubMed ID: 19441676
[TBL] [Abstract][Full Text] [Related]
16. Role of adiponectin and PBEF/visfatin as regulators of inflammation: involvement in obesity-associated diseases.
Tilg H; Moschen AR
Clin Sci (Lond); 2008 Feb; 114(4):275-88. PubMed ID: 18194136
[TBL] [Abstract][Full Text] [Related]
17. Biological background and role of adiponectin as marker for insulin resistance and cardiovascular risk.
Schöndorf T; Maiworm A; Emmison N; Forst T; Pfützner A
Clin Lab; 2005; 51(9-10):489-94. PubMed ID: 16285470
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular actions of adiponectin: pathophysiologic implications.
Maia-Fernandes T; Roncon-Albuquerque R; Leite-Moreira AF
Rev Port Cardiol; 2008 Nov; 27(11):1431-49. PubMed ID: 19227810
[TBL] [Abstract][Full Text] [Related]
19. Adiponectin, obesity and atherosclerosis.
Behre CJ
Scand J Clin Lab Invest; 2007; 67(5):449-58. PubMed ID: 17763181
[TBL] [Abstract][Full Text] [Related]
20. Adiponectin: from obesity to cardiovascular disease.
Antoniades C; Antonopoulos AS; Tousoulis D; Stefanadis C
Obes Rev; 2009 May; 10(3):269-79. PubMed ID: 19389061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
